CytoMed Therapeutics Limited
$0.91
+0.00 (+0.00%)
Price as of Sep 01, 2026 market close
Performance
- 1 Month
- -1.1%
- 3 Months
- -20.3%
- YTD
- -31.9%
- 1 Year
- -54.6%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 94.0%
- Largest decline max drawdown, since Aug 2025
- -73.1%
- Risk-adjusted return Sharpe ratio, 1-year
- -0.38
Own GDTC?
See how GDTC contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.